Walleye Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Walleye Trading’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-51,900	Closed	-$5.03M	–	4835
2019 Q3	$5.03M	Sell	51,900 -4,300	-8%	-$431K	0.04%	467
2019 Q2	$5.75M	Sell	56,200 -31,700	-36%	-$3.42M	0.05%	381
2019 Q1	$10M	Buy	+87,900	New	+$6.46M	0.08%	247
2018 Q4	–	Sell	-12,300	Closed	-$671K	–	5706
2018 Q3	$671K	Buy	+12,300	New	+$841K	﹤0.01%	2550
2018 Q2	–	Sell	-10,100	Closed	-$673K	–	5113
2018 Q1	$673K	Buy	+10,100	New	+$583K	﹤0.01%	2347

Walleye Trading's ONCE Position: Q4 2019 in Review

Walleye Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 33,309 shares — an estimated $3.23M sold.

Walleye Trading first reported a position in ONCE in Q3 2018 and held it in 3 quarters. The position peaked at $6.17M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Walleye Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Walleye Trading sold 33,309 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $3.23M.
Walleye Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
Walleye Trading's Spark Therapeutics, Inc. Common Stock position peaked at $6.17M in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Walleye Trading's 13F filing for Q4 2019, filed 14 Feb 2020.